Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03885232
Other study ID # 17-1274
Secondary ID 1R01HD093628-01A
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date December 2023

Study information

Verified date September 2023
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of this project is to determine whether a novel and innovative provider communication strategy is effective in improving vaccine acceptance among vaccine-hesitant parents (VHPs) and visit experience among VHPs and their health care providers.


Description:

The primary goal of this covariate constrained, cluster randomized controlled trial is to evaluate the effectiveness of an innovative provider communication strategy (PIVOT-MI) intervention in improving provider-parent vaccine discussions and increasing vaccine acceptance. Providers at intervention clinics will be trained to use the PIVOT-MI strategy in which a presumptive format is used to initiate the childhood vaccine recommendation with all parents, followed by use of motivational interviewing (MI) with parents who voice resistance to that recommendation. Providers at control clinics will deliver care as usual. Specific aims are to evaluate the impact of PIVOT-MI, relative to control, on (1) child's immunization status; (2) parent-rated visit experience with their child's provider; and (3) change in provider experience of the vaccine discussion with vaccine-hesitant parents.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 8620
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 1 Day to 18 Months
Eligibility Inclusion Criteria: - Parents: must be English or Spanish speaking, =18 years old, have an infant =18 months old, have legal guardianship of the infant, and is receiving pediatric care at an enrolled clinic - Providers: All providers at participating study practices will be eligible to participate. Exclusion Criteria: - Parents: not English or Spanish speaking, under 18 years old, have an infant older than 18 months, not the legal guardian of the infant, and/or having a child who is not receiving pediatric care at an enrolled clinic. - Providers: Providers who are not at participating study practices.

Study Design


Related Conditions & MeSH terms

  • Preventive Health Services (PREV HEALTH SERV)

Intervention

Behavioral:
Experimental: PIVOT with MI
Providers in participating intervention clinics will be trained in the PIVOT-MI strategy in which a presumptive format is used to initiate the childhood vaccine recommendation with all parents followed by use of motivational interviewing (MI) with parents who voice resistance to that recommendation. Parent participants will receive PIVOT-MI.
Other:
Active Comparator: Control
Providers at participating control clinics will deliver care as usual. Parent participants will receive standard care.

Locations

Country Name City State
United States University of Colorado Anschutz Medical Campus Aurora Colorado
United States Seattle Children's Hospital Seattle Washington

Sponsors (8)

Lead Sponsor Collaborator
University of Colorado, Denver Children's Mercy Hospital Kansas City, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Portland State University, Seattle Children's Hospital, University of Missouri, Kansas City, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Child's Immunization Status Immunization status will be obtained from either state's immunization registry or directly from the participating practices. Child's immunization status at 19 months of age
Secondary Parent Visit Experience Survey To assess parent visit experience, we will administer surveys to all vaccine hesitant parents within 24-48 hours after the completion of their health supervision visit. (Update: Due to COVID-19 restrictions, we have extended the time frame to within 1 week after their health supervision visit) Within 1 week after a health supervision visit
Secondary Change in Provider Perception of Vaccine Discussion - Pre- Interim- and Post-Surveys To assess provider perception of the vaccine discussion with parents, we will administer surveys to all study providers at baseline, interim and at study completion to establish changes in provider perception. At Baseline (year 1), Interim (year 3) and Post-Intervention (years 4 and 5)